Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-276229
Filing Date
2025-11-12
Accepted
2025-11-12 09:15:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 pro_supp_dec_2025_atm_bl.htm 424B3 16938
2 GRAPHIC img203481157_0.jpg GRAPHIC 33760
  Complete submission text file 0001193125-25-276229.txt   62598
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

EIN.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-277758 | Film No.: 251469670
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)